James Hippel, Chief Financial Officer at BIO-TECHNE Corp (TECH), sold 17,500 shares at $451.07 ($8.0M) on 2021-07-12, disclosed to the SEC on 2021-07-14.
Open-market sale of $8.0M TECH by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $451.07 | 600 | $271K | 3.4% |
| 2 | $451.95 | 751 | $339K | 4.2% |
| 3 | $451.95 | 751 | $339K | 4.2% |
| 4 | $453.21 | 788 | $357K | 4.5% |
| 5 | $453.21 | 788 | $357K | 4.5% |
| 6 | $454.15 | 662 |
| $301K |
| 3.8% |
| 7 | $454.15 | 662 | $301K | 3.8% |
| 8 | $455.57 | 1,773 | $808K | 10.1% |
| 9 | $455.57 | 1,773 | $808K | 10.1% |
| 10 | $456.41 | 527 | $241K | 3.0% |
| 11 | $456.41 | 527 | $241K | 3.0% |
| 12 | $457.79 | 1,136 | $520K | 6.5% |
| 13 | $457.79 | 1,136 | $520K | 6.5% |
| 14 | $458.81 | 1,863 | $855K | 10.7% |
| 15 | $458.81 | 1,863 | $855K | 10.7% |
| 16 | $459.64 | 800 | $368K | 4.6% |
| 17 | $460.71 | 600 | $276K | 3.5% |
| 18 | $462.08 | 300 | $139K | 1.7% |
| 19 | $463.56 | 100 | $46K | 0.6% |
| 20 | $466.44 | 100 | $47K | 0.6% |
| Total | $456.40 avg | 17,500 | $8.0M | 100% |
| Filing → |
| TECH | SELL | 2021-09-07 | $10.1M | — | Filing → |
| TECH | SELL | 2021-08-10 | $4.8M | — | Filing → |
| TECH | SELL | 2021-06-09 | $6.8M | — | Filing → |